These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 11207263)

  • 21. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.
    Liu Z; Lefrançois L
    J Immunol; 2004 Oct; 173(7):4324-30. PubMed ID: 15383561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance.
    DePaolo RW; Rollins BJ; Kuziel W; Karpus WJ
    J Immunol; 2003 Oct; 171(7):3560-7. PubMed ID: 14500652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholera toxin breakdowns oral tolerance via activation of canonical NF-κB.
    Kim KJ; Kim HA; Seo KH; Lee HK; Kang BY; Im SY
    Cell Immunol; 2013; 285(1-2):92-9. PubMed ID: 24140867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migratory CD103
    Gribonika I; Strömberg A; Chandode RK; Schön K; Lahl K; Bemark M; Lycke N
    Mucosal Immunol; 2024 Aug; 17(4):509-523. PubMed ID: 38492746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakdown of mucosal immunity in the gut and resultant systemic sensitization by oral antigens in a murine model for systemic lupus erythematosus.
    Akadegawa K; Ishikawa S; Sato T; Suzuki J; Yurino H; Kitabatake M; Ito T; Kuriyama T; Matsushima K
    J Immunol; 2005 May; 174(9):5499-506. PubMed ID: 15843548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of cytotoxic T-lymphocyte-associated antigen-4 in the inductive phase of oral tolerance.
    Chen Y; Ma Y; Chen Y
    Immunology; 2002 Feb; 105(2):171-80. PubMed ID: 11872092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal vaccination and immune responses in the elderly.
    Fujihashi K; Koga T; McGhee JR
    Vaccine; 2000 Feb; 18(16):1675-80. PubMed ID: 10689147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
    Williamson E; Bilsborough JM; Viney JL
    J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice.
    Peng X; Cebra JJ; Adler MW; Meissler JJ; Cowan A; Feng P; Eisenstein TK
    J Immunol; 2001 Oct; 167(7):3677-81. PubMed ID: 11564781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant.
    Wilson AD; Bailey M; Williams NA; Stokes CR
    Eur J Immunol; 1991 Oct; 21(10):2333-9. PubMed ID: 1833201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
    Gärdby E; Lycke NY
    Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles.
    Salman HH; Gamazo C; Agüeros M; Irache JM
    Vaccine; 2007 Nov; 25(48):8123-32. PubMed ID: 18029067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of L-selectin delays mucosal B cell responses in nonintestinal effector tissues.
    Csencsits KL; Pascual DW
    J Immunol; 2002 Nov; 169(10):5649-59. PubMed ID: 12421944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
    Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
    J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally administered cholera toxin prevents murine intestinal T cells from staphylococcal enterotoxin B-induced anergy.
    Iijima H; Takahashi I; Hiroi T; Shimaoka M; Kawano S; Nagano K; Hori M; Kiyono H
    Gastroenterology; 1998 Nov; 115(5):1197-204. PubMed ID: 9797375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
    Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
    J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.